SkyePharma Non CFC MDI
Proprietary Formulation Technologies:
- SkyeFine™: addition of CO2 /NO2, resulting in higher fine particle fractions for both solution and suspension aerosols
- SkyeProtect™: addition of an excipient to improve formulation stability and to reduce absorption losses.
- SkyeDry™: addition of a bulking agent to improve stability of difficult molecules in solution/suspension HFA-MDIs
Leading to innovative, patent protected products